190 related articles for article (PubMed ID: 9328437)
1. Decreases in phorbol ester-induced papilloma development in v-Ha-ras transgenic TG.AC mice during reduced gene dosage of bcl-2.
Trempus CS; Haseman JK; Tennant RW
Mol Carcinog; 1997 Sep; 20(1):68-77. PubMed ID: 9328437
[TBL] [Abstract][Full Text] [Related]
2. Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene.
Spalding JW; Momma J; Elwell MR; Tennant RW
Carcinogenesis; 1993 Jul; 14(7):1335-41. PubMed ID: 8330346
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
4. Focal transgene expression associated with papilloma development in v-Ha-ras-transgenic TG.AC mice.
Hansen LA; Tennant R
Mol Carcinog; 1994 Mar; 9(3):143-54. PubMed ID: 7908201
[TBL] [Abstract][Full Text] [Related]
5. A farnesyl transferase inhibitor suppresses TPA-mediated skin tumor development without altering hyperplasia in the ras transgenic Tg.AC mouse.
Trempus CS; Bishop WR; Njoroge FG; Doll RJ; Battalora MS; Mahler JF; Haseman JK; Tennant RW
Mol Carcinog; 2000 Jan; 27(1):24-33. PubMed ID: 10642434
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic analysis of malignant skin tumors induced in chemically treated TG-AC transgenic mice.
French JE; Libbus BL; Hansen L; Spalding J; Tice RR; Mahler J; Tennant RW
Mol Carcinog; 1994 Dec; 11(4):215-26. PubMed ID: 7999263
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse.
Battalora MS; Spalding JW; Szczesniak CJ; Cape JE; Morris RJ; Trempus CS; Bortner CD; Lee BM; Tennant RW
Carcinogenesis; 2001 Apr; 22(4):651-9. PubMed ID: 11285202
[TBL] [Abstract][Full Text] [Related]
8. Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC mice.
Hansen LA; Trempus CS; Mahler JF; Tennant RW
Carcinogenesis; 1996 Sep; 17(9):1825-33. PubMed ID: 8824502
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of wound-induced v-Ha-ras transgene expression and papilloma development in transgenic Tg.AC mice.
Cannon RE; Spalding JW; Trempus CS; Szczesniak CJ; Virgil KM; Humble MC; Tennant RW
Mol Carcinog; 1997 Sep; 20(1):108-14. PubMed ID: 9328441
[TBL] [Abstract][Full Text] [Related]
10. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin.
Smith MK; Trempus CS; Gilmour SK
Carcinogenesis; 1998 Aug; 19(8):1409-15. PubMed ID: 9744537
[TBL] [Abstract][Full Text] [Related]
11. Homozygous K5Cre transgenic mice have wavy hair and accelerated malignant progression in a murine model of skin carcinogenesis.
Chan EL; Peace BE; Toney K; Kader SA; Pathrose P; Collins MH; Waltz SE
Mol Carcinog; 2007 Jan; 46(1):49-59. PubMed ID: 17013830
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of SEPA 0009-induced tumorigenesis in v-rasHa transgenic Tg.AC mice.
Fuhrman J; Shafer L; Repertinger S; Chan T; Hansen LA
Toxicol Pathol; 2005; 33(6):623-30. PubMed ID: 16176921
[TBL] [Abstract][Full Text] [Related]
13. Loss of critical palindromic transgene promoter sequence in chemically induced Tg.AC mouse skin papillomas expressing transgene-derived mRNA.
Thompson KL; Rosenzweig BA; Honchel R; Cannon RE; Blanchard KT; Stoll RE; Sistare FD
Mol Carcinog; 2001 Dec; 32(4):176-86. PubMed ID: 11746829
[TBL] [Abstract][Full Text] [Related]
14. Effect of the viable-yellow (A(vy)) agouti allele on skin tumorigenesis and humoral hypercalcemia in v-Ha-ras transgenic TGxAC mice.
Hansen LA; Malarkey DE; Wilkinson JE; Rosenberg M; Woychik RE; Tennant RW
Carcinogenesis; 1998 Oct; 19(10):1837-45. PubMed ID: 9806167
[TBL] [Abstract][Full Text] [Related]
15. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
[TBL] [Abstract][Full Text] [Related]
16. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
[TBL] [Abstract][Full Text] [Related]
17. A transgenic mouse model (TG.AC) for skin carcinogenesis: inducible transgene expression as a second critical event.
Hansen LA; Spalding JW; French JE; Tennant RW
Prog Clin Biol Res; 1995; 391():223-35. PubMed ID: 8532720
[TBL] [Abstract][Full Text] [Related]
18. TGF alpha is dispensable for skin tumorigenesis in Tg.AC mice.
Humble MC; Szczesniak CJ; Luetteke NC; Spalding JW; Cannon RE; Hansen LA; Lee DC; Tennant RW
Toxicol Pathol; 1998; 26(4):562-9. PubMed ID: 9715516
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.
Wei SJ; Chang RL; Merkler KA; Gwynne M; Cui XX; Murthy B; Huang MT; Xie JG; Lu YP; Lou YR; Jerina DM; Conney AH
Carcinogenesis; 1999 Sep; 20(9):1689-96. PubMed ID: 10469612
[TBL] [Abstract][Full Text] [Related]
20. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
